| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.2M | — |
| R&D Expense | $30.1M | -48.6% |
| SG&A Expense | $12.6M | +2.4% |
| Operating Income | -$40.5M | +42.9% |
| Interest Expense | $75K | +435.7% |
| Net Income | -$37.9M | +48.5% |
| EPS (Basic) | -$7.73 | -1020.3% |
| EPS (Diluted) | -$7.73 | -1020.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $763K | — |
| Current Assets | $5.4M | -76.2% |
| Total Assets | $5.4M | -76.2% |
| Current Liabilities | $38.9M | +54.7% |
| Long-term Debt | $14.2M | -30.3% |
| Total Liabilities | $38.9M | +16.7% |
| Stockholders' Equity | -$33.5M | -215.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.9M | +61.2% |
| Financing Cash Flow | $11.4M | +812.3% |